Companies: 10,795·Total market cap: $144.5T

Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc.

MNMDNASDAQHealthcare

$20.69

+$0.09(+0.44%)

Market Cap$1.6B

P/E Ratio—

52W High$21.08

52W Low$4.7

Avg Volume2.5M

Open$20.15

Beta2.62

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Mind Medicine (MindMed) Inc.（MNMD）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MNMD · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-2.50Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding89.3MShares outstanding history

Next EarningsTBAEarnings history

探索 Mind Medicine (MindMed) Inc. 数据

分析师预测$20 · Buy

股息不分红

盈利EPS $-2.06-33.77%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$183.8M▼ 69.12% YoY

202320242025

FY 2025EPS$-2.06▼ 33.77% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$237.5MEPS: $-2.50View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$14.00Low

$20.69Current

$20.00Avg Target下行风险 3.33%

$28.00High

合计: 1 · 买入占比: 100.0%

根据过去 3 个月内 1 位华尔街分析师，MNMD 共识评级为 Buy，12 个月平均目标价 $20.00 （较现价 $20.69 下行风险 3.33%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Mind Medicine (MindMed) Inc.

$20.69+0.44%$1.6B #2

AnaptysBio, Inc.

$50.88+2.03%$2.2B #3

BridgeBio Oncology Therapeutics Inc.

$7.91+0.70%$633.6M #4

Fortrea Holdings Inc.

$16.78+3.92%$1.6B #5

Kodiak Sciences Inc.

$30.51-2.51%$1.6B #6

Nurix Therapeutics, Inc.

$15.88+5.94%$1.4B

股票表现

1D-5.44%

1W-8.04%

1M+0.05%

3M+13.49%

YTD+54.52%

1Y+198.56%

5Y-56.76%

关于 Mind Medicine (MindMed) Inc.

CEORobert Barrow

IPO DateNov 15, 2016

Employees74

CountryCA

Websitemindmed.co

Mind Medicine (MindMed) Inc. a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company dev…

Biotechnology HealthcareNASDAQCA

关于股票概览与关键数据

Mind Medicine (MindMed) Inc.（MNMD）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 15, 2016 在 NASDAQ 上市。截至最近交易日，MNMD 股价为 $20.69，市值约为 $1.6B。过去12个月累计回报 +198.56%，年初至今回报 +54.52%。

根据 1 位华尔街分析师，Mind Medicine (MindMed) Inc. 股票共识评级为Buy，12个月平均目标价为 $20.00。2025 财年 Mind Medicine (MindMed) Inc. 营收 —，净利润 -$183.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Mind Medicine (MindMed) Inc.（MNMD）股价为 $20.69，在 NASDAQ 上市，52周区间为 $4.70 – $21.08。

MNMD 最新股价MNMD quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议